Malignant hyperpyrexia during general anesthesia. Successful management of a case.
D000293:Adolescent; D000768:Anesthesia, General / Q000009:adverse effects*; D001639:Bicarbonates / Q000627:therapeutic use; D001831:Body Temperature; D002746:Chlorpromazine / Q000627:therapeutic use; D003907:Dexamethasone / Q000627:therapeutic use; D005260:Female; D005947:Glucose / Q000627:therapeutic use; D006801:Humans; D008305:Malignant Hyperthermia / Q000139:chemically induced / Q000188:drug therapy / Q000628:therapy*; D011343:Procaine / Q000627:therapeutic use; D012007:Rectum; D012964:Sodium / Q000009:adverse effects / Q000627:therapeutic use; D013390:Succinylcholine / Q000009:adverse effects; D013874:Thiopental / Q000009:adverse effects; D013997:Time Factors; D014867:Water
D001639:Bicarbonates; D014867:Water; D011343:Procaine; D003907:Dexamethasone; D012964:Sodium; D005947:Glucose; D013390:Succinylcholine; D013874:Thiopental; D002746:Chlorpromazine